Trust Investment Advisors Eli Lilly & CO Transaction History

Trust Investment Advisors

$153 Million
Q2 2024

A detailed history of Trust Investment Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Trust Investment Advisors holds 21,922 shares of LLY stock, worth $17 Million. This represents 12.94% of its overall portfolio holdings.

Number of Shares

21,922

Previous 17,386 26.09%

Holding current value

$17 Million

Previous $13.5 Million 46.74%

% of portfolio

12.94%

Previous 9.89%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $3.29 Million - $4.12 Million	4,536 Added 26.09%	21,922 $19.8 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $116,071 - $155,286	-196 Reduced 1.11%	17,386 $13.5 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $277,825 - $327,519	-529 Reduced 2.92%	17,582 $10.2 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $259,515 - $357,782	-597 Reduced 3.19%	18,111 $9.73 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $189,048 - $252,780	539 Added 2.97%	18,708 $8.77 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $333,927 - $392,181	-1,075 Reduced 5.59%	18,169 $6.24 Million
Q4 2022 Feb 28, 2023	BUY	$321.55 - $374.67 $6.19 Million - $7.21 Million	19,244 New	19,244 $7.04 Million
Q3 2022 Nov 02, 2022	SELL	$296.48 - $337.87 $266,832 - $304,083	-900 Reduced 4.59%	18,729 $6.06 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $483,317 - $567,486	1,734 Added 9.69%	19,629 $6.36 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $12,438 - $15,457	-53 Reduced 0.3%	17,895 $5.12 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $20,011 - $24,834	89 Added 0.5%	17,948 $4.96 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $258,607 - $318,252	-1,167 Reduced 6.13%	17,859 $4.13 Million
Q2 2021 Jul 23, 2021	BUY	$180.55 - $233.54 $5,055 - $6,539	28 Added 0.15%	19,026 $4.37 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $270,799 - $350,562	-1,648 Reduced 7.98%	18,998 $3.55 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $8,349 - $11,048	-64 Reduced 0.31%	20,646 $3.49 Million
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $40,925 - $49,254	-300 Reduced 1.43%	20,710 $3.4 Million
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $83,335 - $103,145	-700 Reduced 3.22%	21,010 $2.92 Million
Q4 2019 Feb 03, 2020	SELL	$106.92 - $132.43 $21,384 - $26,486	-200 Reduced 0.91%	21,710 $2.85 Million
Q3 2019 Oct 24, 2019	SELL	$106.79 - $116.16 $74,753 - $81,312	-700 Reduced 3.1%	21,910 $2.45 Million
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $213,270 - $248,941	-1,925 Reduced 7.85%	22,610 $2.51 Million
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $44,524 - $52,408	-400 Reduced 1.6%	24,535 $3.18 Million
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $31,770 - $35,592	-300 Reduced 1.19%	24,935 $2.89 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $2,146 - $2,682	-25 Reduced 0.1%	25,235 $2.71 Million
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $15,140 - $17,376	-200 Reduced 0.79%	25,260 $2.16 Million
Q1 2018 May 29, 2018	SELL	$74.21 - $87.6 $96,472 - $113,879	-1,300 Reduced 4.86%	25,460 $1.97 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $66,453 - $71,278	-811 Reduced 2.94%	26,760 $2.26 Million
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $2.12 Million - $2.36 Million	27,571	27,571 $2.36 Million

Others Institutions Holding LLY

# of Institutions

3,916

Shares Held

765M

Call Options Held

6.34M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $738B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Trust Investment Advisors with notifications on news.

Account

Trust Investment Advisors Eli Lilly & CO Transaction History